Netmed IncOver The Counter Market:NTME
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Netmed Inc | 10.0 | 0.0x | --- |
Evolutionary Genomics Inc | 5.3K | 0.0x | --- |
Pathfinder Cell Therapy Inc | 670.0 | 0.0x | --- |
Cantabio Pharmaceuticals Inc | 22.8K | 0.0x | --- |
Better Therapeutics Inc | 50.0 | 0.0x | --- |
FutureWorld Corp | 5.2K | 0.0x | --- |
Company Information
NetMed, Inc. has no business activities. During the fiscal year ended December 31, 2001, the Company's sole business activity, through its majority-owned subsidiary, OxyNet, Inc., involved research and development activities associated with a proprietary ceramic-based technology for separation of oxygen from ambient air and other gases. These activities were suspended effective December 31, 2001, pending efforts to locate a prospective licensee or development partner. The Company is continuing efforts, begun in 2001, to evaluate other business opportunities, which included preliminary investigation and due diligence. These efforts have not, in the judgment of the Company's management, produced an attractive merger or acquisition candidate. The Company is seeking a candidate with a proprietary product or service, which may be in the development stage, and offers an opportunity to realize these objectives.
Contact Information
- Headquarters
- 1999 Bryan St Ste 900DALLAS, TX, United States 75201-3140
- Phone
- 614-793-9356
- Fax
- 614-793-9376
Executives
- President, Chief Executive Officer, Director
- S. Trevor Ferger
- Vice President-Finance
- Kenneth Leachman
- Director
- Michael Blue
- Director
- Robert Massey
- Director
- Susan O'Toole
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.00 |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 13.7M |
Netmed Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.02 |
Book Value | $0.06 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
